EUVIMEDEUVIMED entdecken
Crossref

Discovery of an Ortho-Substituted N -Cyclopropylmethyl-7α-phenyl-6,14- endo ethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative Effect

Zixiang Li, Rufeng Ye, Qian He, Jiashuo Lu, Yanting Sun, Xiujian Sun, Siyuan Tang, Shuyang Hu, Jingrui Chai, Linghui Kong iD, Xiaoning Liu, Jing Chen und 8 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.3c02439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Zixiang Li und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, Fudan University, No. 826 Zhangheng Road, Shanghai 201203, China. Hauptthemen laut MEDLINE: Receptors, Opioid, kappa. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Research into kappa opioid receptor (KOR) agonists with attenuated central-nervous-system side effects is a critical focus for developing productive and safe analgesics. Herein, a series of ortho-substituted N-cyclopropylmethyl-7α-phenyl-6,14-endoethano-tetrahydronorthebaines were designed, synthesized, and subjected to bioassays. Compound 7a exhibited high subtype selectivity and potent agonistic activity toward KOR (KOR, Ki = 3.9 nM, MOR/KOR = 270, DOR/KOR = 1075; [35S]GTPγS binding, EC50 = 3.4 nM). Additionally, this compound exhibited robust and persistent antinociceptive effects in rodent models with different animal strains (hot plate test, ED50 = 0.20-0.30 mg/kg, i.p.; abdominal constriction test, ED50 = 0.20-0.60 mg/kg, i.p.), with its KOR-mediated mechanism for antinociception firmly established. Notably, compound 7a, unlike conventional KOR agonists, displayed minimal sedation and aversion at the antinociceptive ED50 dose. This feature addresses a crucial limitation in existing KOR agonists, positioning compound 7a as a promising novel therapeutic agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Opioid, kappaAnimalsMiceStructure-Activity RelationshipMaleHumansHypnotics and SedativesRatsAnalgesicsDrug DiscoveryRats, Sprague-DawleyCricetulus

Substanzen

Receptors, Opioid, kappaHypnotics and SedativesAnalgesics

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, School of Pharmacy, Fudan University, No. 826 Zhangheng Road, Shanghai 201203, China.
  • CAS Key Laboratory of Receptor Research and State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Road, Shanghai 201203, China.
  • University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.
  • Department of Pharmacy, Dalian Medical University, Dalian 116044, China.
  • Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Key Laboratory of Acupuncture and Neurobiology of Zhejiang Province, Hangzhou 310053, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, Shandong, China.

ORCID-Profile: Linghui Kong, Qiong Xie, Liming Shao, Wei Fu, Wei Li

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China
  • Shenzhen-Hong Kong Institute of Brain Science
  • Shenzhen Fundamental Research Institutions

Zitieren

APA

Li, Z., Ye, R., He, Q., Lu, J., Sun, Y., Sun, X., Tang, S., Hu, S., Chai, J., Kong, L., Liu, X., Chen, J., Fang, Y., Lan, Y., Xie, Q., Liu, J., Shao, L., Fu, W., Wang, Y., & Li, W. (2024). Discovery of an Ortho-Substituted N -Cyclopropylmethyl-7α-phenyl-6,14- endo ethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative Effect. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c02439

Vancouver

Li Z, Ye R, He Q, Lu J, Sun Y, Sun X, et al. Discovery of an Ortho-Substituted N -Cyclopropylmethyl-7α-phenyl-6,14- endo ethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative Effect. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c02439

BibTeX
@article{Li2024,
  author = {Li, Zixiang and Ye, Rufeng and He, Qian and Lu, Jiashuo and Sun, Yanting and Sun, Xiujian and Tang, Siyuan and Hu, Shuyang and Chai, Jingrui and Kong, Linghui and Liu, Xiaoning and Chen, Jing and Fang, Yun and Lan, Yingjie and Xie, Qiong and Liu, Jinggen and Shao, Liming and Fu, Wei and Wang, Yujun and Li, Wei},
  title = {Discovery of an Ortho-Substituted N -Cyclopropylmethyl-7α-phenyl-6,14- endo ethano-tetrahydronorthebaine Derivative as a Selective and Potent Kappa Opioid Receptor Agonist with Subsided Sedative Effect},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.3c02439}
}
Kostenlos starten →